InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-14.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by BEHRENS M KATHLEEN, Director. Director active across 3 companies, notably Mimedx Group, INC.. Cumulatively, 37 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1.9m. History available since 27 May 2021. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations37 total
16,875 sharesCommon StockSEC:0001193125-26-260257:0
1,471 shares0Common StockSEC:0001415889-25-009777:0
2,383 sharesCommon StockSEC:0000950170-25-037511:0
3,078 shares0Common StockSEC:0001415889-25-000608:0
3,078 shares0Common StockSEC:0001415889-24-024533:0
746 shares0Common StockSEC:0000950170-24-104194:0
15,000 shares@ US$13.9014.3% of flowCommon StockSEC:0000950170-24-082240:0
3,078 shares0Common StockSEC:0001415889-24-019056:0
23,190 shares@ US$7.2620.2% of flowCommon StockSEC:0001376339-24-000047:0
3,078 shares0Common StockSEC:0001415889-24-009849:0
1,846 shares0Common StockSEC:0000950170-24-026618:0
800 shares0Common StockSEC:0001209191-24-000520:0
15,000 shares@ US$29.0330.3% of flowCommon StockSEC:0001209191-23-054440:0
800 shares0Common StockSEC:0001209191-23-051739:0
800 shares0Common StockSEC:0001209191-23-041386:0
112,500 shares@ US$8.0044.6% of flowCommon StockSEC:0001209191-23-040091:0
Ideal exit: 22 Mar 2024 (T+270)
35,354 shares@ US$4.9521.1% of flowCommon StockSEC:0001376339-23-000041:0
800 shares0Common StockSEC:0001209191-23-022973:0
1,523 shares0Common StockSEC:0001209191-23-017402:0
374 shares0Common StockSEC:0001209191-23-001103:0
20,000 shares@ US$34.9248.8% of flowCommon StockSEC:0001209191-22-062287:0
60,000 shares@ US$17.142555.4% of flowCommon StockSEC:0001209191-22-056423:0
Ideal exit: 5 Aug 2023 (T+270)
374 shares0Common StockSEC:0001209191-22-051985:0
374 shares0Common StockSEC:0001209191-22-040886:0
44,191 shares@ US$3.960.016% mcap36.3% of flowCommon StockSEC:0001376339-22-000089:0
25 of 37 declarations
About BEHRENS M KATHLEEN
Kathleen M. Behrens is a Board Member at Mimédx Group, Inc., IGM Biosciences, Inc., and Sarepta Therapeutics, Inc. She brings her expertise to guide strategic decisions and ensure compliance within these companies.
